July 23, 2014 9:08 PM ET


Company Overview of IGY Immune Technologies & Life Sciences Inc.

Company Overview

IGY Immune Technologies & Life Sciences Inc. engages in the extraction of polyclonal antibodies for nutraceutical and pharmaceutical applications for human and animal consumption. Its antibodies are derived from chicken eggs. The company’s products are used in medicines, functional foods, agriculture/feeds, and cosmeceuticals. IGY Immune Technologies & Life Sciences Inc. was founded in 2009 and is based in Thunder Bay, Canada.

40 South Cumberland Street

Thunder Bay, ON P7B 2T5


Founded in 2009





Key Executives for IGY Immune Technologies & Life Sciences Inc.

Chief Financial Officer
Age: 59
Director of Research and Consultant
Compensation as of Fiscal Year 2014.

IGY Immune Technologies & Life Sciences Inc. Key Developments

IGY Life Sciences Announces North American Launch of Vector450, an Athlete Immune Health Dietary Supplement

IGY Immune Technologies & Life Sciences Inc. announced the launch of its new sports nutrition supplement brand Vector450 aimed at the athlete market. Vector450 works safely and effectively at the gut level to modulate the immune system and functions to improve its efficiency. The risk of an impaired immune system for top athletes is further exacerbated by other factors such as the exposure to new pathogens through travel, lack of proper sleep, weight loss, mental stress, inadequate nutrition or adoption of unusual diets. The consequences of an impaired immune function for athletes are missed workouts or competitions, and a general decrease in performance. Vector450 contains Muno-IgY, a purified IgY protein naturally extracted from hen eggs. What sets Muno-IgY apart from any other product available on the market is the high purity of the ingredient. And with its new technology, IGY Life Sciences can finally offer consumers a cost-effective, highly-purified product priced at $35 for a bottle of 60 capsules. IgY antibodies have been closely studied and documented for their ability to target many specific pathogens. Muno-IgY is not aimed toward any individual pathogen, but toward maintaining a strong immune system. Having an optimal immune system can lead to improved stamina along with increased anaerobic power and decreased submaximal heart rate, shorter exercise recovery times and faster muscle repair while supporting the body's natural process of inflammatory balance.

Similar Private Companies By Industry

Company Name Region
Neo-Nutritionals, Inc. Americas
Wyeth Canada, Inc. Americas
Simply Marketing Inc. Americas
PanGeo Quebec Pharma Inc. Americas
Canagen Pharmaceuticals Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IGY Immune Technologies & Life Sciences Inc., please visit www.igylifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.